Home › Funds › Alkeon Capital Management › RYTM
Alkeon Capital Management position in RYTM
RHYTHM PHARMACEUTICALS INC · Health Care
Latest position (Q3 2025)1.02M sh
Reported value held$102.78M
Portfolio Weight0.15%
First reportedQ2 2022
Last changeHold
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2022 | 1.50M | $6.22M | New |
| Q3 2022 | 1.71M | $41.77M | Add |
| Q4 2022 | 2.24M | $65.18M | Add |
| Q1 2023 | 2.02M | $35.96M | Reduce |
| Q2 2023 | 1.73M | $28.45M | Reduce |
| Q3 2023 | 1.73M | $39.55M | Hold |
| Q2 2024 | 1.00M | $41.06M | New |
| Q3 2024 | 1.17M | $61.18M | Add |
| Q4 2024 | 1.17M | $65.37M | Hold |
| Q1 2025 | 817.70K | $43.31M | Reduce |
| Q2 2025 | 1.02M | $64.31M | Add |
| Q3 2025 | 1.02M | $102.78M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding RYTM
- BlackRock Inc 6.16M sh · $683.60M · Q2 2026
- Vanguard Group 6.21M sh · $664.82M · Q4 2025
- JPMorgan Chase & Co 2.65M sh · $292.18M · Q2 2026
- Goldman Sachs Group 2.13M sh · $236.11M · Q2 2026
- Geode Capital Management 1.53M sh · $170.32M · Q2 2026
- Capital Research Global Investors 1.53M sh · $170.13M · Q2 2026
- Citadel Advisors 1.31M sh · $145.36M · Q2 2026
- Morgan Stanley 1.11M sh · $123.49M · Q2 2026
- Fidelity Management & Research (FMR) 1.03M sh · $113.90M · Q2 2026
- Janus Henderson Group 918.15K sh · $79.89M · Q1 2026
- Norges Bank Investment Management 685.84K sh · $76.15M · Q2 2026
- Franklin Resources 577.03K sh · $64.07M · Q2 2026